Waleed Barakat

Waleed Barakat

Auto-generated profile, based on publicly available information

Waleed Barakat

Department of Pharmacology & Toxicology, Faculty of Pharmacy, Zagazig University, Egypt

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2008 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SMSajjad Muhammad
Sajjad Muhammad
WBWaleed Barakat
Waleed Barakat
SSStoyan Stoyanov
Stoyan Stoyanov
SMSasidhar Murikinati
Sasidhar Murikinati
HYHuan Yang
Huan Yang
MSMarkus Schwaninger
Markus Schwaninger
In ischemic stroke, the necrotic core is surrounded by a zone of inflammation, in which delayed cell death aggravates the initial insult. Here, we provide evidence that the receptor for advanced glycation end products (RAGE) functions as a sensor of necrotic cell death and contributes to inflammation and ischemic brain damage. The RAGE ligand high mobility group box 1 (HMGB1) was elevated in serum of stroke patients and was released from ischemic brain tissue in a mouse model of cerebral ischemia. A neutralizing anti-HMGB1 antibody and HMGB1 box A, an antagonist of HMGB1 at the receptor RAGE, ameliorated ischemic brain damage. Interestingly, genetic RAGE deficiency and the decoy receptor soluble RAGE reduced the infarct size.In vitro, expression of RAGE in (micro)glial cells mediated the toxic effect of HMGB1. Addition of macrophages to neural cultures further enhanced the toxic effect of HMGB1. To test whether immigrant macrophages in the ischemic brain mediate the RAGE effect, we generated chimeric mice by transplanting RAGE−/−bone marrow to wild-type mice. RAGE deficiency in bone marrow-derived cells significantly reduced the infarct size. Thus, HMGB1–RAGE signaling links necrosis with macrophage activation and may provide a target for anti-inflammatory therapy in stroke.

6 December 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Panagiotis BargiotasPanagiotis Bargiotas
Panagiotis Bargiotas
AKAntje Krenz
Antje Krenz
SHSheriar G. Hormuzdi
Sheriar G. Hormuzdi
DRDirk A. Ridder
Dirk A. Ridder
AHAnne Herb
Anne Herb
MSMarkus Schwaninger
Markus Schwaninger
Pannexin 1 (Px1, Panx1) and pannexin 2 (Px2, Panx2) form large-pore nonselective channels in the plasma membrane of cells and were suggested to play a role in the pathophysiology of cerebral ischemia. To directly test a potential contribution of pannexins in ischemia-related mechanisms, we performed experiments in Px1 −/− , Px2 −/− , and Px1 −/− Px2 −/− knockout mice. IL-1β release, channel function in astrocytes, and cortical spreading depolarization were not altered in Px1 −/− Px2 −/− mice, indicating that, in contrast to previous concepts, these processes occur normally in the absence of pannexin channels. However, ischemia-induced dye release from cortical neurons was lower, indicating that channel function in Px1 −/− Px2 −/− neurons was impaired. Furthermore, Px1 −/− Px2 −/− mice had a better functional outcome and smaller infarcts than wild-type mice when subjected to ischemic stroke. In conclusion, our data demonstrate that Px1 and Px2 underlie channel function in neurons and contribute to ischemic brain damage.

1 December 2014 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
SSSamira Saleh
Samira Saleh
NENabila El-Maraghy
Nabila El-Maraghy
EREnji Reda
Enji Reda
WBWaleed Barakat
Waleed Barakat
Mangiferin, present in Mangifera indica bark, was reported to produce hypoglycemic and antidiabetic activity in an animal model of genetic type 2 diabetes and in streptozotocin diabetic rats. Its effect on diabetic insulin-resistant animals has not been investigated. The current work aimed to explore the effect of mangiferin on diabetic insulin-resistant rat model. Diabetes was induced by high-fat/high fructose diet for eight weeks followed by a subdiabetogenic dose of streptozotocin (HFD-Fr-STZ). Rats were treated with mangiferin (20 mg/kg i.p.) for 28 days starting one week after STZ and its effects were compared to the standard insulin sensitizer, rosiglitazone. HFD-Fr-STZ, induced obesity, hyperglycemia and insulin resistance accompanied by depletion in liver glycogen and dyslipidemia. Moreover, there was an elevation in serum TNF-α and a reduction in adiponectin. Mangiferin ameliorated the consequences of HFD-Fr-STZ and its actions were comparable to the effects of the standard insulin sensitizer, rosiglitazone. The results obtained in this study provide evidence that mangiferin is a possible beneficial natural compound for type 2 diabetes and metabolic disorders associated with the metabolic syndrome. This effect is mediated through improving insulin sensitivity, modulating lipid profile and reverting adipokine levels to normal.

21 November 2018 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
ASAmira Saleh
Amira Saleh
HEHassan M. ElFayoumi
Hassan M. ElFayoumi
PYProf. M. Youns
Prof. M. Youns
WBWaleed Barakat
Waleed Barakat

1 February 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
WBWaleed Barakat
Waleed Barakat
NSNancy Safwet
Nancy Safwet
NENabila N. El-Maraghy
Nabila N. El-Maraghy
MZMohamed N.M. Zakaria
Mohamed N.M. Zakaria

8 February 2012 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MMMona F. Mahmoud
Mona F. Mahmoud
MMMona F. Mahmoud
Mona F. Mahmoud
WBWaleed Barakat
Waleed Barakat